SABS · ISSUER CIK 1833214
SAB Biotherapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 SAB Biotherapeutics, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Sep 18, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 202616:15 | Sep 17, 2026 | SABS | CHIEF MEDICAL OFFICER | F · Tax | — | −473 | 41,853 | -1% | — |